Photo: DNA
Johnson & Johnson Seeks Approval For Single-Dose Vaccine Launch
US-based pharmaceutical company Johnson & Johnson (J&J) to likely launch a single-dose vaccine against COVID-19 for emergency use in India. Reportedly, the government is yet to approve the proposal. The company also said they aim to launch the vaccine in collaboration with Hyderabad-based Biological E Limited. Notably, the vaccine's phase three clinical trial shows an efficiency of 85% against the Covid-19 strain.
Tags: Johnson & Johnson, Covid-19 Vaccine, Single-dose, Indian government, vaccine
Courtesy: Scroll.in
